Linus Jönsson, Anders Wimo, Ron Handels, Gunilla Johansson, Mercè Boada, Sebastiaan Engelborghs, . . . Bengt Winblad. (2023). The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: An EADC-EC viewpoint. Elsevier.
Chicago Style (17th ed.) CitationLinus Jönsson, et al. The Affordability of Lecanemab, an Amyloid-targeting Therapy for Alzheimer's Disease: An EADC-EC Viewpoint. Elsevier, 2023.
MLA (9th ed.) CitationLinus Jönsson, et al. The Affordability of Lecanemab, an Amyloid-targeting Therapy for Alzheimer's Disease: An EADC-EC Viewpoint. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.